Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. The Royal Marsden Hospital

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Royal Marsden Hospital, located at 203 Fulham Rd., London SW3 6JJ, is the main London site of a world-renowned, specialist National Health Service (NHS) oncology trust. Founded by surgeon William Marsden in 1851, it holds the historic distinction of being the world's first hospital dedicated entirely to cancer diagnosis, treatment, research, and education. Alongside its sister site in Sutton, Surrey, and its academic partner, the Institute of Cancer Research (ICR), the facility constitutes the largest comprehensive cancer centre in Europe. Celebrated for its cutting-edge medical advancements—including hosting Europe's largest drug trials unit—and officially rated "Outstanding" by the UK's Care Quality Commission (CQC), the Chelsea-based hospital delivers highly integrated, world-class diagnostics, therapies, and inpatient care to over 59,000 NHS and private patients every year.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Trial-derived.
96Total Trials
Source: Trial-derived.
28Recruiting Trials
Source: Trial-derived.
50Active Trials
Source: Trial-derived.
36Completed Trials
Source: Trial-derived.
165Unique Conditions
Source: Trial-derived.
97Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (6)Source: Trial-derived. Cancer (5)Source: Trial-derived. Metastatic Breast Cancer (4)Source: Trial-derived. Prostate Cancer (4)Source: Trial-derived. Breast Neoplasms (3)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (3)Source: Trial-derived. Multiple Myeloma (3)Source: Trial-derived. Advanced Cancer (2)

Sponsors

Source: Trial-derived. Royal Marsden NHS Foundation Trust (20)Source: Trial-derived. Pfizer (11)Source: Trial-derived. Seagen, a wholly owned subsidiary of Pfizer (8)Source: Trial-derived. AbbVie (7)Source: Trial-derived. Institute of Cancer Research, United Kingdom (6)Source: Trial-derived. AstraZeneca (5)Source: Trial-derived. Merck Sharp & Dohme LLC (5)Source: Trial-derived. Replimune, Inc. (5)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. MRI
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. CT Scan
Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. RAS mutation testing
Source: AI-inferred. Radiographic tumour response assessment